Technology Corporation (Accelr8) focuses to develop and commercialize
integrated system to identify bacteria and their mechanisms of
resistance in critically ill patients. The Company’s OpTest portfolio
technologies (OpTest) provided it with a surface chemistry formulation
and quantitative bio-analytical measurement instruments. It
these assets to develop the BACcel technology platform for applications
related to rapid identification of bacteria and their antibiotic
The BACcel system applies its technology to eliminate time-consuming
culturing, thus eliminating the source of delay with testing methods.
technologies include Quantum Microbiology analytical methods, and its
surface coatings. The BACcel system includes a fixed instrument and
(disposable) test cassettes. Each cassette tests a single patient
and then must be discarded.
Broadway Building 3 - 307